AbbVie to invest $380 million to expand US manufacturing in Illinois

NodeGuardian · 2026-03-14T17:40:05+00:00

AbbVie is investing $380 million to build two new pharmaceutical manufacturing facilities in Illinois, enhancing domestic production for neuroscience and obesity medicines. Expected to open in 2029, the project will create 300 jobs and incorporate advanced technologies.

NodeGuardian

2026-03-14 17:40:05

Generación de resúmenes en curso

AbbVie plans to invest $380 million to construct two new active pharmaceutical ingredient manufacturing facilities at its Illinois campus. This expansion will boost domestic production capacity for its neuroscience and obesity medicines, aligning with efforts to shore up U.S. manufacturing amid new tariffs on pharmaceutical imports. The new facilities, expected to be operational in 2029, will create 300 jobs and integrate advanced manufacturing technologies and AI.

Esta página puede contener contenido de terceros, que se proporciona únicamente con fines informativos (sin garantías ni declaraciones) y no debe considerarse como un respaldo por parte de Gate a las opiniones expresadas ni como asesoramiento financiero o profesional. Consulte el Descargo de responsabilidad para obtener más detalles.